ABIO 13F Hedge Fund and Asset Management Owners

Data as of 2021-05-08 10:56:26 -0400
Market Cap	46.545 Million	Shares Outstanding	14.41 Million	Avg 30-day Volume	338.724 Thousand
P/E Ratio		Dividend Yield		EPS
Price/Sales		Debt to Equity		EBITDA
Price to Book Value	0.0	Forward PE		Enterprise Value
Total Cash		Current Debt		Gross Profit
BETA	0.22205	52-week High/Low	22.0 / 3.05	Next Earnings Date		Price to Cash FLow (P/CF)	-9999999.0
				Data provided by IEX Cloud

Q4 2020	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change
In top 10:	0	0		0 (0.0%)	0 (0.0%)
Funds Holding:	21	16	31.25%	5 (0.3%)	4 (0.25%)	25.0%
13F shares:	821.335 Thousand	412.187 Thousand	99.26%	295.098 Thousand	66.722 Thousand	342.28%
% Ownership	8.8112	4.4219	99.26%	3.1658	0.7158	342.27%
New Positions:	10	8	25.0%	4	3	33.33%
Increased Positions	4	3	33.33%	1
Closed Positions	5	1	400.0%	3	1	200.0%
Reduced Positions		2			1
Total Calls	59
Total Puts	12.5 Thousand
PUT/CALL Ratio	211.86
¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding ABIO (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABIO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

20 Thousand total shares from 2 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
CONWAY ROBERT E	Director CHAIRMAN OF THE BOARD	50,000	2021-05-13	7
DEKKER C. JEFFREY CHIEF FINANCIAL OFFICER	Officer	0	2021-05-10	1
GRAIS LINDA	Director	0	2021-01-12	1
WOOSLEY RAYMOND L.	Director	0	2021-01-12	1
MITCHELL DANIEL J	Director	611	2021-01-12	1
HOVE ANDERS D	Director	0	2021-01-12	1
OZEROFF CHRISTOPHER DAVID S.V.P., GENERAL COUNSEL	Officer	970	2020-12-21	1
BRISTOW MICHAEL R PRES. & CHIEF EXECUTIVE OFFIC	Officer Director	4,808	2020-12-21	1
SELBY BRIAN L. VP, FINANCE	Officer	0	2020-12-21	1
KEUER THOMAS A CHIEF OPERATING OFFICER	Officer	730	2020-12-21	1
MAKOWER JOSHUA	10% Owner	No longer subject to file	2018-02-26	0
SAKODA JON	10% Owner	No longer subject to file	2018-02-26	0
GROWTH EQUITY OPPORTUNITIES IV, LLC NEW ENTERPRISE ASSOCIATES 15, L.P. NEA PARTNERS 15, L.P. NEA 15 GP, LLC	10% Owner	No longer subject to file	2018-02-26	0
SONSINI PETER W.	10% Owner	No longer subject to file	2018-02-26	0
BARRIS PETER J	10% Owner	No longer subject to file	2018-02-26	0
BASKETT FOREST	10% Owner	No longer subject to file	2018-02-26	0
MOTT DAVID M	10% Owner	No longer subject to file	2018-02-26	0
FLORENCE ANTHONY A. JR.	10% Owner	No longer subject to file	2018-02-26	0
SANDELL SCOTT D	10% Owner	No longer subject to file	2018-02-26	0
VISWANATHAN RAVI	10% Owner	No longer subject to file	2018-02-26	0
VENROCK HEALTHCARE CAPITAL PARTNERS LP VHCP CO-INVESTMENT HOLDINGS, LLC VHCP MANAGEMENT, LLC VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. VHCP CO-INVESTMENT HOLDINGS II, LLC VHCP MANAGEMENT II, LLC KOH BONG Y SHAH NIMISH P	10% Owner	No longer subject to file	2018-02-26	0
VENROCK HEALTHCARE CAPITAL PARTNERS LP VENROCK HEALTHCARE CAPITAL PARTNERS II, L.P. VHCP CO-INVESTMENT HOLDINGS, LLC VHCP CO-INVESTMENT HOLDINGS II, LLC KOH BONG Y HOVE ANDERS D VHCP MANAGEMENT, LLC VHCP MANAGEMENT II, LLC	10% Owner	10,789,324	2015-06-16	0
WELLER HARRY R	10% Owner	10,221,465	2015-06-16	0
KOLLURI KRISHNA KITTU	10% Owner	10,221,465	2015-06-16	0
MCCORMACK RILEY	10% Owner	No longer subject to file	2015-01-14	0
WHEELER PATRICK M CHIEF FINANCIAL OFFICER	Officer	101,510	2014-09-18	0
ZABRISKIE JOHN L	Director	0	2013-09-17	0
ATLAS VENTURE FUND VII L P ATLAS VENTURE ASSOCIATES VII, L.P.	10% Owner	1,579,542	2012-10-25	0
FORMELA JEAN FRANCOIS	Director 10% Owner	1,579,542	2012-10-22	0
BREWER RICHARD B	Director	0	2012-02-10	0
SOBEL BURTON E	Director	0	2012-02-10	0
ATLAS VENTURE FUND VII L P	10% Owner	1,337,612	2010-03-29	0
PENDERGAST MARY K	Director	0	2010-02-05	0
FREYTAG J WILLIAM	Director	0	2010-02-05	0
LOVE TED W	Director	0	2010-02-05	0
LOWE DAVID GEORGE	Director	No longer subject to file	2009-07-17	0
FALBERG KATHRYN E CFO AND COO	Officer	0	2009-06-25	0
SKYLINE VENTURE PARTNERS QUALIFIED PURCHASER FUND IV L P	FORMER 10% OWNER	No longer subject to file	2009-06-11	0
BOULDER VENTURES IV ANNEX LP BOULDER VENTURES IV LP BV PARTNERS IV, L.L.C. FIDLER JOSH E JONES ANDREW E LEFKOFF KYLE MACKS LAWRENCE M ROSHKO PETER	10% Owner	No longer subject to file	2009-04-06	0
ST LAURENT RANDALL EVP COMMERCIAL OPERATIONS	Officer	0	2009-01-27	0
BENDEKGEY E LEE CFO AND TREASURER	Officer	1,502	2008-12-31	0
GAVIN JAMES R III	Director	0	2008-06-04	0
PERRY MARK L	Director	0	2008-06-04	0
POPOVITS KIMBERLY J	Director	0	2008-06-04	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
CONWAY ROBERT E - Director CHAIRMAN OF THE BOARD	2021-05-13 17:00:43 -0400	2021-05-12	P	10,000	$3.19	a	50,000	direct
CONWAY ROBERT E - Director CHAIRMAN OF THE BOARD	2021-05-06 16:30:31 -0400	2021-05-05	P	10,000	$3.23	a	40,000	direct		-5.2632	0.0		0.0	1	-5.2632	2

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available
ARCA BIOPHARMA INC ABIO	2021-05-14 22:15:03 UTC	-1.3117	1.3617	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 21:45:03 UTC	-1.3117	1.3617	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 21:15:03 UTC	-1.3117	1.3617	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 20:45:03 UTC	-1.3117	1.3617	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 20:15:04 UTC	-1.3117	1.3617	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 19:45:02 UTC	-1.3117	1.3617	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 19:15:03 UTC	-1.3117	1.3617	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 18:45:03 UTC	-1.3042	1.3542	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 18:15:03 UTC	-1.3042	1.3542	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 17:45:03 UTC	-1.3042	1.3542	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 17:15:03 UTC	-1.3042	1.3542	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 16:45:03 UTC	-1.3174	1.3674	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 16:15:03 UTC	-1.3174	1.3674	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 15:45:03 UTC	-1.3174	1.3674	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 15:15:02 UTC	-1.3174	1.3674	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 14:45:04 UTC	-1.3092	1.3592	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 14:15:03 UTC	-1.3092	1.3592	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 13:45:03 UTC	-1.3092	1.3592	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 13:15:03 UTC	-1.3092	1.3592	300000
ARCA BIOPHARMA INC ABIO	2021-05-14 12:45:03 UTC	-1.3092	1.3592	250000

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin

Arca Biopharma Inc YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Arca Biopharma Inc (ABIO)

WhaleWisdom Alpha

Our Other Reporting & Analysis